|
GS168673: MP:0010329 abnormal lipoprotein level
|
|
GS185131: GO:0044699 single-organism process
|
|
GS121709: 15-deoxyprostaglandin J2 interacting genes (MeSH:C477819) in CTD
|
|
GS202082: GO:0051254 positive regulation of RNA metabolic process
|
|
GS170581: MP:0008987 abnormal liver lobule morphology
|
|
GS182704: GO:0051172 negative regulation of nitrogen compound metabolic process
|
|
GS125652: Adrenergic beta-Antagonists interacting genes (MeSH:D000319) in CTD
|
|
GS184458: GO:0009892 negative regulation of metabolic process
|
|
GS136552: proteinuria 5 (Ptnu5, Published QTL Chr 15)
|
|
GS185261: GO:0051254 positive regulation of RNA metabolic process
|
|
GS34146: Cerebellum Gene expression correlates of Open Field Total34 horizontal distance (cm) 45-60 min post 2nd cocaine in Females BXD
|
|
GS185715: GO:0006110 regulation of glycolysis
|
|
GS183512: GO:0019217 regulation of fatty acid metabolic process
|
|
GS169076: MP:0002079 increased circulating insulin level
|
|
GS183480: GO:0014070 response to organic cyclic compound
|
|
GS121514: Paraquat interacting genes (MeSH:D010269) in CTD
|
|
GS203018: GO:0045935 positive regulation of nucleobase-containing compound metabolic process
|
|
GS186120: GO:0090077 foam cell differentiation
|
|
GS169815: MP:0006264 decreased systemic arterial systolic blood pressure
|
|
GS125688: Arachidonic Acid interacting genes (MeSH:D016718) in CTD
|
|
GS136932: vertebral trabecular bone trait 17 (Vtbt17, Published QTL Chr 15)
|
|
GS205697: GO:0032099 negative regulation of appetite
|
|
GS166257: MP:0005291 abnormal glucose tolerance
|
|
GS205780: GO:0044723 single-organism carbohydrate metabolic process
|
|
GS169830: MP:0005384 cellular phenotype
|
|
GS190997: GO:0044281 small molecule metabolic process
|
|
GS200555: GO:0010605 negative regulation of macromolecule metabolic process
|
|
GS178388: GO:0055114 oxidation-reduction process
|
|
GS122014: Fatty Acids, Unsaturated interacting genes (MeSH:D005231) in CTD
|
|
GS190247: GO:0032403 protein complex binding
|
|
GS165382: MP:0001260 increased body weight
|
|
GS165308: MP:0004848 abnormal liver size
|
|
GS121789: (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine interacting genes (MeSH:C516138) in CTD
|
|
GS192816: GO:0070491 repressing transcription factor binding
|
|
GS205762: GO:0070166 enamel mineralization
|
|
GS123377: Glucose interacting genes (MeSH:D005947) in CTD
|
|
GS196934: GO:0065008 regulation of biological quality
|
|
GS206940: GO:0032095 regulation of response to food
|
|
GS202930: GO:2000113 negative regulation of cellular macromolecule biosynthetic process
|
|
GS199550: GO:0032787 monocarboxylic acid metabolic process
|
|
GS178188: GO:0034440 lipid oxidation
|
|
GS121750: Linoleic Acid interacting genes (MeSH:D019787) in CTD
|
|
GS125587: Reactive Oxygen Species interacting genes (MeSH:D017382) in CTD
|
|
GS163666: MP:0005278 abnormal cholesterol homeostasis
|
|
GS199273: GO:0043233 organelle lumen
|
|
GS122851: lipopolysaccharide, Escherichia coli 0111 B4 interacting genes (MeSH:C440499) in CTD
|
|
GS191019: GO:0034641 cellular nitrogen compound metabolic process
|
|
GS123012: GW 9578 interacting genes (MeSH:C121804) in CTD
|
|
GS122521: Nitric Oxide interacting genes (MeSH:D009569) in CTD
|
|
GS135724: dissociation of activity 2 (Disso2, Published QTL Chr 15)
|
|
GS197042: GO:0010888 negative regulation of lipid storage
|
|
GS165218: MP:0001240 abnormal epidermis stratum corneum morphology
|
|
GS195685: GO:0003707 steroid hormone receptor activity
|
|
GS187887: GO:0080090 regulation of primary metabolic process
|
|
GS188243: GO:0051101 regulation of DNA binding
|
|
GS125035: GW 6471 interacting genes (MeSH:C449302) in CTD
|
|
GS125973: atorvastatin interacting genes (MeSH:C065179) in CTD
|
|
GS135475: brachyury modifier 2 (Brm2, Published QTL Chr 15)
|
|
GS178814: GO:0046982 protein heterodimerization activity
|
|
GS205788: GO:0044724 single-organism carbohydrate catabolic process
|
|
GS189669: GO:2000112 regulation of cellular macromolecule biosynthetic process
|
|
GS126646: Carbon Tetrachloride interacting genes (MeSH:D002251) in CTD
|
|
GS127102: sulindac sulfone interacting genes (MeSH:C025463) in CTD
|
|
GS206108: GO:2001141 regulation of RNA biosynthetic process
|
|
GS163376: MP:0009763 increased sensitivity to induced morbidity/mortality
|
|
GS192017: GO:0006139 nucleobase-containing compound metabolic process
|
|
GS136865: T cell receptor induced activation 2 (Tria2, Published QTL Chr 15)
|
|
GS168906: MP:0011117 abnormal susceptibility to weight gain
|
|
GS169491: MP:0006055 abnormal vascular endothelial cell morphology
|
|
GS126037: Fibric Acids interacting genes (MeSH:D058607) in CTD
|
|
GS200311: GO:0019216 regulation of lipid metabolic process
|
|
GS178588: GO:0045892 negative regulation of transcription, DNA-dependent
|
|
GS186215: GO:0048519 negative regulation of biological process
|
|
GS177265: GO:0048731 system development
|
|
GS207925: GO:0034645 cellular macromolecule biosynthetic process
|
|
GS201251: GO:0044424 intracellular part
|
|
GS193238: GO:0031323 regulation of cellular metabolic process
|
|
GS129102: bone mineral density 4 (Bmd4 Published QTL Chr 15)
|
|
GS203908: GO:0016070 RNA metabolic process
|
|
GS181893: GO:0048522 positive regulation of cellular process
|
|
GS188142: GO:0048856 anatomical structure development
|
|
GS135629: collagen induced arthritis 35 (Cia35, Published QTL Chr 15)
|
|
GS122195: Gentamicins interacting genes (MeSH:D005839) in CTD
|
|
GS36295: Hippocampus Gene expression correlates of Open Field InovelTOTAL locomotion (activity beam breaks) in the center in BXD Males
|
|
GS207827: GO:0072369 regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter
|
|
GS189433: GO:0043467 regulation of generation of precursor metabolites and energy
|
|
GS84289: cocaine related behavior (Published QTL, Chr 15)
|
|
GS126466: Quercetin interacting genes (MeSH:D011794) in CTD
|
|
GS196988: GO:0045595 regulation of cell differentiation
|
|
GS166698: MP:0003961 decreased lean body mass
|
|
GS183543: GO:0051179 localization
|
|
GS163455: MP:0005658 increased susceptibility to diet-induced obesity
|
|
GS209551: GO:0031981 nuclear lumen
|
|
GS194937: GO:0034440 lipid oxidation
|
|
GS35645: Whole Brain Gene expression correlates of Morphine photocell counts minutes 45-60 in Males BXD
|
|
GS125271: Thiophanate interacting genes (MeSH:D013875) in CTD
|
|
GS124870: Adenosine Triphosphate interacting genes (MeSH:D000255) in CTD
|
|
GS190917: GO:0072364 regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter
|
|
GS164958: MP:0001239 abnormal epidermis stratum granulosum morphology
|
|
GS122861: Phenylpropionates interacting genes (MeSH:D010666) in CTD
|
|
GS207823: GO:0072367 regulation of lipid transport by regulation of transcription from RNA polymerase II promoter
|
|
GS208495: GO:0072329 monocarboxylic acid catabolic process
|
|
GS193414: GO:0044249 cellular biosynthetic process
|
|
GS166979: MP:0004130 abnormal muscle cell glucose uptake
|
|
GS202555: GO:0043436 oxoacid metabolic process
|
|
GS195563: GO:0032368 regulation of lipid transport
|
|
GS165595: MP:0010545 abnormal heart layer morphology
|
|
GS182752: GO:0032787 monocarboxylic acid metabolic process
|
|
GS182978: GO:0033993 response to lipid
|
|
GS191728: GO:0008289 lipid binding
|
|
GS163824: MP:0001259 abnormal body weight
|
|
GS124932: chiglitazar interacting genes (MeSH:C515629) in CTD
|
|
GS136321: non-HDL QTL 9 (Nhdlq9, Published QTL Chr 15)
|
|
GS166591: MP:0004087 abnormal muscle fiber morphology
|
|
GS206190: GO:0048585 negative regulation of response to stimulus
|
|
GS180371: GO:0046321 positive regulation of fatty acid oxidation
|
|
GS188784: GO:0008134 transcription factor binding
|
|
GS34330: Cerebellum Gene expression correlates of Cocaine TOTAL locomotion ( cm in 1 hr) in Females BXD
|
|
GS178922: GO:0003700 sequence-specific DNA binding transcription factor activity
|
|
GS127197: Carnitine interacting genes (MeSH:D002331) in CTD
|
|
GS204106: GO:0060089 molecular transducer activity
|
|
GS36166: Striatum Gene expression correlates of Locomotor activity of mice on Day 1 in Females & Males BXD
|
|
GS184456: GO:0009894 regulation of catabolic process
|
|
GS34557: Hippocampus Gene expression correlates of Novel environment locomotion (activity beam breaks) 45-60 min in the periphery in BXD Males
|
|
GS122712: anthra(1,9-cd)pyrazol-6(2H)-one interacting genes (MeSH:C432165) in CTD
|
|
GS178730: GO:0030534 adult behavior
|
|
GS188757: GO:0009887 organ morphogenesis
|
|
GS183513: GO:0019216 regulation of lipid metabolic process
|
|
GS84288: METH responses for home cage activity (Published QTL, Chr 15)
|
|
GS170733: MP:0000188 abnormal circulating glucose level
|
|
GS193937: GO:0006366 transcription from RNA polymerase II promoter
|
|
GS135960: HDL QTL 27 (Hdlq27, Published QTL Chr 15)
|
|
GS189106: GO:0008015 blood circulation
|
|
GS184620: GO:0043392 negative regulation of DNA binding
|
|
GS201367: GO:0019538 protein metabolic process
|
|
GS188828: GO:0032096 negative regulation of response to food
|
|
GS167127: MP:0005280 abnormal fatty acid level
|
|
GS195340: GO:0045893 positive regulation of transcription, DNA-dependent
|
|
GS196808: GO:0032501 multicellular organismal process
|
|
GS123233: LY 171883 interacting genes (MeSH:C044660) in CTD
|
|
GS178913: GO:0042221 response to chemical stimulus
|
|
GS186744: GO:0043226 organelle
|
|
GS136113: liver Gapd decay rate 2 (Lgdr2, Published QTL Chr 15)
|
|
GS182835: GO:0005622 intracellular
|
|
GS189224: GO:0007610 behavior
|
|
GS213074: Genes with suggestive difference in (B6PF1) vs (PB6F1 + B6 + PWD) comparison
|
|
GS122986: Ginsenosides interacting genes (MeSH:D036145) in CTD
|
|
GS164468: MP:0001560 abnormal circulating insulin level
|
|
GS180207: GO:0045596 negative regulation of cell differentiation
|
|
GS182509: GO:0001085 RNA polymerase II transcription factor binding
|
|
GS182703: GO:0051171 regulation of nitrogen compound metabolic process
|
|
GS210178: GO:0031328 positive regulation of cellular biosynthetic process
|
|
GS136637: salmonella enteritidis susceptibility 3 (Ses3, Published QTL Chr 15)
|
|
GS163583: MP:0001554 increased circulating free fatty acid level
|
|
GS192779: GO:0000122 negative regulation of transcription from RNA polymerase II promoter
|
|
GS196261: GO:0042157 lipoprotein metabolic process
|
|
GS198360: GO:0006357 regulation of transcription from RNA polymerase II promoter
|
|
GS203406: GO:0009653 anatomical structure morphogenesis
|
|
GS186790: GO:0006725 cellular aromatic compound metabolic process
|
|
GS169075: MP:0002078 abnormal glucose homeostasis
|
|
GS186634: GO:0044092 negative regulation of molecular function
|
|
GS136513: prion incubation time 4 (Pitm4, Published QTL Chr 15)
|
|
GS136561: QTL for body weight independent of sex 4 (Qbis4, Published QTL Chr 15)
|
|
GS168683: MP:0000598 abnormal liver morphology
|
|
GS194111: GO:0097159 organic cyclic compound binding
|
|
GS208187: GO:0010033 response to organic substance
|
|
GS125412: Triglycerides interacting genes (MeSH:D014280) in CTD
|
|
GS204150: GO:0009611 response to wounding
|
|
GS136057: IgA nephropathy QTL 3 (Ignpq3, Published QTL Chr 15)
|
|
GS124866: sulindac sulfide interacting genes (MeSH:C025462) in CTD
|
|
GS135630: collagen induced arthritis 37 (Cia37, Published QTL Chr 15)
|
|
GS180372: GO:0046320 regulation of fatty acid oxidation
|
|
GS202762: GO:0004879 ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity
|
|
GS126758: Folic Acid interacting genes (MeSH:D005492) in CTD
|
|
GS200341: GO:0051179 localization
|
|
GS206742: GO:0043167 ion binding
|
|
GS199861: GO:0032104 regulation of response to extracellular stimulus
|
|
GS194778: GO:0042180 cellular ketone metabolic process
|
|
GS190391: GO:0032870 cellular response to hormone stimulus
|
|
GS205645: GO:0008134 transcription factor binding
|
|
GS163929: MP:0002891 increased insulin sensitivity
|
|
GS123108: 15-deoxy-delta(12,14)-prostaglandin J2 interacting genes (MeSH:C097240) in CTD
|
|
GS189751: GO:0050794 regulation of cellular process
|
|
GS163052: MP:0000266 abnormal heart morphology
|
|
GS185258: GO:0051253 negative regulation of RNA metabolic process
|
|
GS187343: GO:0006351 transcription, DNA-dependent
|
|
GS195668: GO:0042221 response to chemical stimulus
|
|
GS34032: Cerebellum Gene expression correlates of Open Field locomotion (cm) 15-30 min post cocaine in Females BXD
|
|
GS209010: GO:1901575 organic substance catabolic process
|
|
GS126584: Tetrachlorodibenzodioxin interacting genes (MeSH:D013749) in CTD
|
|
GS203369: GO:0005654 nucleoplasm
|
|
GS124857: perfluorooctane sulfonic acid interacting genes (MeSH:C076994) in CTD
|
|
GS191212: GO:0009605 response to external stimulus
|
|
GS121381: fumonisin B1 interacting genes (MeSH:C056933) in CTD
|
|
GS181473: GO:0005488 binding
|
|
GS180036: GO:0032501 multicellular organismal process
|
|
GS121178: Linolenic Acids interacting genes (MeSH:D008042) in CTD
|
|
GS192345: GO:0010628 positive regulation of gene expression
|
|
GS127056: diethyl maleate interacting genes (MeSH:C014476) in CTD
|
|
GS196930: GO:0065007 biological regulation
|
|
GS200312: GO:0019219 regulation of nucleobase-containing compound metabolic process
|
|
GS124953: 2,4-dinitrotoluene interacting genes (MeSH:C016403) in CTD
|
|
GS188413: GO:0045834 positive regulation of lipid metabolic process
|
|
GS191311: GO:1901215 negative regulation of neuron death
|
|
GS177859: GO:0045944 positive regulation of transcription from RNA polymerase II promoter
|
|
GS191150: GO:0010557 positive regulation of macromolecule biosynthetic process
|
|
GS205792: GO:0031331 positive regulation of cellular catabolic process
|
|
GS197709: GO:0046365 monosaccharide catabolic process
|
|
GS208955: GO:0006006 glucose metabolic process
|
|
GS124163: Streptozocin interacting genes (MeSH:D013311) in CTD
|
|
GS35430: Whole Brain Gene expression correlates of Distance traveled (cm) during the second five minute bin after saline in Females BXD
|
|
GS83996: cocaine seizure 3 (Cosz3, Published QTL, Chr 15)
|
|
GS167928: MP:0010630 abnormal cardiac muscle tissue morphology
|
|
GS202954: GO:0090077 foam cell differentiation
|
|
GS195142: GO:0016054 organic acid catabolic process
|
|
GS169389: MP:0002060 abnormal skin morphology
|
|
GS180262: GO:0010889 regulation of sequestering of triglyceride
|
|
GS194947: GO:0019915 lipid storage
|
|
GS167542: MP:0001790 abnormal immune system physiology
|
|
GS167319: MP:0003947 abnormal cholesterol level
|
|
GS203058: GO:0048519 negative regulation of biological process
|
|
GS204746: GO:0080090 regulation of primary metabolic process
|
|
GS135425: bile mucin accumulation (Bmca, Published QTL Chr 15)
|
|
GS163601: MP:0002089 abnormal postnatal growth/weight/body size
|
|
GS177094: GO:0006629 lipid metabolic process
|
|
GS201249: GO:0044428 nuclear part
|
|
GS197244: GO:0044237 cellular metabolic process
|
|
GS201264: GO:0009890 negative regulation of biosynthetic process
|
|
GS125627: Diglycerides interacting genes (MeSH:D004075) in CTD
|
|
GS125599: Dichloroacetate interacting genes (MeSH:D003999) in CTD
|
|
GS192680: GO:0038023 signaling receptor activity
|
|
GS198456: GO:0019438 aromatic compound biosynthetic process
|
|
GS168793: MP:0005439 decreased glycogen level
|
|
GS184884: GO:0010941 regulation of cell death
|
|
GS194088: GO:0003676 nucleic acid binding
|
|
GS167228: MP:0005317 increased triglyceride level
|
|
GS165527: MP:0005378 growth/size phenotype
|
|
GS186776: GO:0010891 negative regulation of sequestering of triglyceride
|
|
GS209199: GO:0007165 signal transduction
|
|
GS200204: GO:0015849 organic acid transport
|
|
GS122060: 2-bromopalmitate interacting genes (MeSH:C022776) in CTD
|
|
GS201262: GO:0009892 negative regulation of metabolic process
|
|
GS135967: HDL QTL 4 (Hdlq4, Published QTL Chr 15)
|
|
GS178589: GO:0045893 positive regulation of transcription, DNA-dependent
|
|
GS178813: GO:0046983 protein dimerization activity
|
|
GS179409: GO:0031624 ubiquitin conjugating enzyme binding
|
|
GS204158: GO:0032800 receptor biosynthetic process
|
|
GS121227: ginsenoside Rf interacting genes (MeSH:C055328) in CTD
|
|
GS199986: GO:0009719 response to endogenous stimulus
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS122436: phthalic acid interacting genes (MeSH:C032279) in CTD
|
|
GS115115: QTL for VEC in the LS x SS RI Strains
|
|
GS198980: GO:0010876 lipid localization
|
|
GS196540: GO:0043565 sequence-specific DNA binding
|
|
GS205492: GO:0010677 negative regulation of cellular carbohydrate metabolic process
|
|
GS121805: Herbicides interacting genes (MeSH:D006540) in CTD
|
|
GS205558: GO:0003013 circulatory system process
|
|
GS208151: GO:0050996 positive regulation of lipid catabolic process
|
|
GS188506: GO:0010467 gene expression
|
|
GS182593: GO:0019902 phosphatase binding
|
|
GS208012: GO:0044464 cell part
|
|
GS189324: GO:0048585 negative regulation of response to stimulus
|
|
GS201239: GO:0046483 heterocycle metabolic process
|
|
GS188763: GO:0009888 tissue development
|
|
GS192073: GO:1901576 organic substance biosynthetic process
|
|
GS188399: GO:0044238 primary metabolic process
|
|
GS208060: GO:0010557 positive regulation of macromolecule biosynthetic process
|
|
GS184435: GO:0046483 heterocycle metabolic process
|
|
GS163855: MP:0000010 abnormal abdominal fat pad morphology
|
|
GS127327: troglitazone interacting genes (MeSH:C057693) in CTD
|
|
GS181851: GO:0045923 positive regulation of fatty acid metabolic process
|
|
GS186214: GO:0048518 positive regulation of biological process
|
|
GS162850: MP:0002908 delayed wound healing
|
|
GS125445: Phenobarbital interacting genes (MeSH:D010634) in CTD
|
|
GS202556: GO:0043434 response to peptide hormone stimulus
|
|
GS205623: GO:0009888 tissue development
|
|
GS184220: GO:0071702 organic substance transport
|
|
GS163277: MP:0011049 impaired adaptive thermogenesis
|
|
GS123718: Ethinyl Estradiol interacting genes (MeSH:D004997) in CTD
|
|
GS167017: MP:0003959 abnormal lean body mass
|
|
GS188820: GO:0032091 negative regulation of protein binding
|
|
GS124852: hydrazine interacting genes (MeSH:C029424) in CTD
|
|
GS200142: GO:0001666 response to hypoxia
|
|
GS177310: GO:1901360 organic cyclic compound metabolic process
|
|
GS167020: MP:0003956 abnormal body size
|
|
GS165789: MP:0005369 muscle phenotype
|
|
GS170073: MP:0001853 heart inflammation
|
|
GS193220: GO:0006082 organic acid metabolic process
|
|
GS179880: GO:0051525 NFAT protein binding
|
|
GS121965: Amiodarone interacting genes (MeSH:D000638) in CTD
|
|
GS191157: GO:0010558 negative regulation of macromolecule biosynthetic process
|
|
GS191151: GO:0010556 regulation of macromolecule biosynthetic process
|
|
GS136421: pain 1 (Pain1, Published QTL Chr 15)
|
|
GS209282: GO:0010628 positive regulation of gene expression
|
|
GS199591: GO:0042060 wound healing
|
|
GS125912: Phenylthiourea interacting genes (MeSH:D010670) in CTD
|
|
GS178448: GO:0005634 nucleus
|
|
GS199635: GO:0005622 intracellular
|
|
GS178759: GO:0031667 response to nutrient levels
|
|
GS125044: Acetaldehyde interacting genes (MeSH:D000079) in CTD
|
|
GS126309: etomoxir interacting genes (MeSH:C054207) in CTD
|
|
GS188832: GO:0032099 negative regulation of appetite
|
|
GS180679: GO:0009628 response to abiotic stimulus
|
|
GS125828: 2-ethylhexanoic acid interacting genes (MeSH:C040668) in CTD
|
|
GS126062: Spironolactone interacting genes (MeSH:D013148) in CTD
|
|
GS208061: GO:0010556 regulation of macromolecule biosynthetic process
|
|
GS125487: palmidrol interacting genes (MeSH:C005958) in CTD
|
|
GS180188: GO:0006869 lipid transport
|
|
GS199860: GO:0032107 regulation of response to nutrient levels
|
|
GS123580: ciprofibrate interacting genes (MeSH:C019304) in CTD
|
|
GS183961: GO:0019395 fatty acid oxidation
|
|
GS193233: GO:0031329 regulation of cellular catabolic process
|
|
GS167323: MP:0003949 abnormal circulating lipid level
|
|
GS122982: ethyl(E,E,E)-7-(2-n-propoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-3-yl)-6-fluorp-3-methylocta-2,4,6-trienoate interacting genes (MeSH:C504648) in CTD
|
|
GS178031: GO:0042180 cellular ketone metabolic process
|
|
GS135663: cocaine seizure 3 (Cosz3, Published QTL Chr 15)
|
|
GS165244: MP:0010771 integument phenotype
|
|
GS123751: Cadmium interacting genes (MeSH:D002104) in CTD
|
|
GS196941: GO:0008150 biological_process
|
|
GS163578: MP:0001553 abnormal circulating free fatty acids level
|
|
GS183067: GO:0032101 regulation of response to external stimulus
|
|
GS191881: GO:0044390 small protein conjugating enzyme binding
|
|
GS195339: GO:0045892 negative regulation of transcription, DNA-dependent
|
|
GS202194: GO:0044242 cellular lipid catabolic process
|
|
GS190893: GO:0030154 cell differentiation
|
|
GS189882: GO:0048545 response to steroid hormone stimulus
|
|
GS201964: GO:0043470 regulation of carbohydrate catabolic process
|
|
GS201256: GO:0044422 organelle part
|
|
GS84290: METH responses for home cage activity (Published QTL, Chr 15)
|
|
GS192344: GO:0010629 negative regulation of gene expression
|
|
GS200030: GO:0032868 response to insulin stimulus
|
|
GS204007: GO:0044700 single organism signaling
|
|
GS126171: Capsaicin interacting genes (MeSH:D002211) in CTD
|
|
GS185147: GO:0043471 regulation of cellular carbohydrate catabolic process
|
|
GS201431: GO:0005515 protein binding
|
|
GS184396: GO:0045776 negative regulation of blood pressure
|
|
GS121647: 2-ethoxy-3-(4-((4-(methylsulfonyloxy)phenethyl)oxy)phenyl)propanoic acid interacting genes (MeSH:C501413) in CTD
|
|
GS136908: vertebral morphology and mechanical traits 13 (Vmmt13, Published QTL Chr 15)
|
|
GS206192: GO:0048583 regulation of response to stimulus
|
|
GS165998: MP:0009598 thin epidermis stratum granulosum
|
|
GS180802: GO:0006096 glycolysis
|
|
GS187247: GO:0060089 molecular transducer activity
|
|
GS209411: GO:0048869 cellular developmental process
|
|
GS126276: pirinixic acid interacting genes (MeSH:C006253) in CTD
|
|
GS187160: GO:0044707 single-multicellular organism process
|
|
GS177761: GO:0044271 cellular nitrogen compound biosynthetic process
|
|
GS190682: GO:0007275 multicellular organismal development
|
|
GS123926: Orotic Acid interacting genes (MeSH:D009963) in CTD
|
|
GS125192: dichlorfop-methyl interacting genes (MeSH:C012891) in CTD
|
|
GS136544: periosteal circumference 3 (Pstc3, Published QTL Chr 15)
|
|
GS168128: MP:0010024 increased total body fat amount
|
|
GS115118: A QTL region for alcohol preference
|
|
GS181783: GO:0010604 positive regulation of macromolecule metabolic process
|
|
GS197039: GO:0010883 regulation of lipid storage
|
|
GS210181: GO:0031325 positive regulation of cellular metabolic process
|
|
GS188631: GO:0010675 regulation of cellular carbohydrate metabolic process
|
|
GS209564: GO:0043231 intracellular membrane-bounded organelle
|
|
GS135658: cocaine related behavior 14 (Cocrb14, Published QTL Chr 15)
|
|
GS125025: oleoylethanolamide interacting genes (MeSH:C488250) in CTD
|
|
GS34106: Cerebellum Gene expression correlates of Open Field locomotion (activity beam breaks) 30-45 min post 2nd cocaine in Females BXD
|
|
GS169915: MP:0005560 decreased circulating glucose level
|
|
GS170693: MP:0004215 abnormal myocardial fiber physiology
|
|
GS189537: GO:0010742 macrophage derived foam cell differentiation
|
|
GS202080: GO:0051252 regulation of RNA metabolic process
|
|
GS184485: GO:0008144 drug binding
|
|
GS210179: GO:0031327 negative regulation of cellular biosynthetic process
|
|
GS163886: MP:0005448 abnormal energy balance
|
|
GS180208: GO:0045595 regulation of cell differentiation
|
|
GS200626: GO:0044262 cellular carbohydrate metabolic process
|
|
GS169827: MP:0005387 immune system phenotype
|
|
GS163853: MP:0001547 abnormal lipid level
|
|
GS170198: MP:0001614 abnormal blood vessel morphology
|
|
GS188924: GO:0044724 single-organism carbohydrate catabolic process
|
|
GS126094: Bezafibrate interacting genes (MeSH:D001629) in CTD
|
|
GS136299: mean platelet volume locus 1 (Mpvq1, Published QTL Chr 15)
|
|
GS198219: GO:0006631 fatty acid metabolic process
|
|
GS204568: GO:0009893 positive regulation of metabolic process
|
|
GS35630: Whole Brain Gene expression correlates of Morphine photocell counts minutes 30-45 in Males BXD
|
|
GS205490: GO:0010675 regulation of cellular carbohydrate metabolic process
|
|
GS181954: GO:0043401 steroid hormone mediated signaling pathway
|
|
GS186899: GO:0016265 death
|
|
GS165207: MP:0002843 decreased systemic arterial blood pressure
|
|
GS186422: GO:0031214 biomineral tissue development
|
|
GS202799: GO:0051049 regulation of transport
|
|
GS209452: GO:0006810 transport
|
|
GS209982: GO:0015908 fatty acid transport
|
|
GS136723: susceptibility to lung cancer 26 (Sluc26, Published QTL Chr 15)
|
|
GS185923: GO:0004879 ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity
|
|
GS204326: GO:0019752 carboxylic acid metabolic process
|
|
GS184460: GO:0009890 negative regulation of biosynthetic process
|
|
GS190059: GO:0032098 regulation of appetite
|
|
GS204021: GO:0044707 single-multicellular organism process
|
|
GS205047: GO:0006807 nitrogen compound metabolic process
|
|
GS184629: GO:0005515 protein binding
|
|
GS208665: GO:0008289 lipid binding
|
|
GS123357: norathyriol interacting genes (MeSH:C069053) in CTD
|
|
GS202463: GO:0006109 regulation of carbohydrate metabolic process
|
|
GS164482: MP:0001216 abnormal epidermal layer morphology
|
|
GS180918: GO:0046365 monosaccharide catabolic process
|
|
GS170777: MP:0000184 abnormal circulating HDL cholesterol level
|
|
GS121664: 1,4-bis(2-(3,5-dichloropyridyloxy))benzene interacting genes (MeSH:C028474) in CTD
|
|
GS209291: GO:0046914 transition metal ion binding
|
|
GS178394: GO:0016052 carbohydrate catabolic process
|
|
GS124398: 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid interacting genes (MeSH:C548544) in CTD
|
|
GS170236: MP:0005452 abnormal adipose tissue amount
|
|
GS123323: Sucrose interacting genes (MeSH:D013395) in CTD
|
|
GS127240: Acetaminophen interacting genes (MeSH:D000082) in CTD
|
|
GS203357: GO:0010869 regulation of receptor biosynthetic process
|
|
GS194458: GO:0051235 maintenance of location
|
|
GS199500: GO:0051172 negative regulation of nitrogen compound metabolic process
|
|
GS194459: GO:0051234 establishment of localization
|
|
GS164555: MP:0005329 abnormal myocardium layer morphology
|
|
GS179211: GO:0007154 cell communication
|
|
GS183062: GO:0032104 regulation of response to extracellular stimulus
|
|
GS126047: Cyanamide interacting genes (MeSH:D003484) in CTD
|
|
GS122852: alitretinoin interacting genes (MeSH:C103303) in CTD
|
|
GS185920: GO:0004872 receptor activity
|
|
GS192265: GO:0007165 signal transduction
|
|
GS169500: MP:0010951 abnormal lipid oxidation
|
|
GS180152: GO:0065007 biological regulation
|
|
GS34022: Cerebellum Gene expression correlates of Open Field locomotion 45-60 min post cocaine in Females BXD
|
|
GS185104: GO:0019318 hexose metabolic process
|
|
GS34089: Cerebellum Gene expression correlates of Open Field rears 45-60 min post cocaine in Females BXD
|
|
GS121922: Nafenopin interacting genes (MeSH:D009255) in CTD
|
|
GS121369: Clofibric Acid interacting genes (MeSH:D002995) in CTD
|
|
GS164908: MP:0010358 abnormal free fatty acids level
|
|
GS168479: MP:0005455 increased susceptibility to weight gain
|
|
GS167832: MP:0003457 abnormal circulating ketone body level
|
|
GS194481: GO:0019899 enzyme binding
|
|
GS201965: GO:0043471 regulation of cellular carbohydrate catabolic process
|
|
GS186488: GO:0048513 organ development
|
|
GS196355: GO:0006820 anion transport
|
|
GS202760: GO:0004871 signal transducer activity
|
|
GS177065: GO:0072363 regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter
|
|
GS178422: GO:0035095 behavioral response to nicotine
|
|
GS170601: MP:0005621 abnormal cell physiology
|
|
GS185366: GO:0044248 cellular catabolic process
|
|
GS135729: darker modification of yellow agouti QTL 3 (Dmyaq3, Published QTL Chr 15)
|
|
GS194627: GO:0008544 epidermis development
|
|
GS192354: GO:0046914 transition metal ion binding
|
|
GS200384: GO:0046395 carboxylic acid catabolic process
|
|
GS184427: GO:0060548 negative regulation of cell death
|
|
GS180060: GO:0071383 cellular response to steroid hormone stimulus
|
|
GS121461: Urea interacting genes (MeSH:D014508) in CTD
|
|
GS187293: GO:0009611 response to wounding
|
|
GS84286: alcohol consumption (Published QTL, Chr 15)
|
|
GS205820: GO:0033036 macromolecule localization
|
|
GS124686: Ibuprofen interacting genes (MeSH:D007052) in CTD
|
|
GS202759: GO:0004872 receptor activity
|
|
GS135901: granulosa cell tumorigenesis 3 (Gct3, Published QTL Chr 15)
|
|
GS170776: MP:0000187 abnormal triglyceride level
|
|
GS189326: GO:0048583 regulation of response to stimulus
|
|
GS190056: GO:0032095 regulation of response to food
|
|
GS125342: Pyridoxal Phosphate interacting genes (MeSH:D011732) in CTD
|
|
GS123506: pioglitazone interacting genes (MeSH:C060836) in CTD
|
|
GS135923: habituation QTL (Hbtq, Published QTL Chr 15)
|
|
GS196806: GO:0032502 developmental process
|
|
GS206618: GO:0050793 regulation of developmental process
|
|
GS124910: pterostilbene interacting genes (MeSH:C107773) in CTD
|
|
GS207282: GO:0031324 negative regulation of cellular metabolic process
|
|
GS208126: GO:0009605 response to external stimulus
|
|
GS203594: GO:0043226 organelle
|
|
GS196966: GO:0006869 lipid transport
|
|
GS178807: GO:0032368 regulation of lipid transport
|
|
GS205364: GO:0010467 gene expression
|
|
GS135692: directional asymmetry QTL 14 (Daq14, Published QTL Chr 15)
|
|
GS122373: Chenodeoxycholic Acid interacting genes (MeSH:D002635) in CTD
|
|
GS126676: Ketoconazole interacting genes (MeSH:D007654) in CTD
|
|
GS194900: GO:0008217 regulation of blood pressure
|
|
GS135992: hepatic fibrogenesis 1 (Hfib1, Published QTL Chr 15)
|
|
GS209622: GO:0038023 signaling receptor activity
|
|
GS125401: Diethylhexyl Phthalate interacting genes (MeSH:D004051) in CTD
|
|
GS209009: GO:1901576 organic substance biosynthetic process
|
|
GS177887: GO:0008544 epidermis development
|
|
GS34136: Cerebellum Gene expression correlates of Open Field locomotion (cm) 30-45 min post 2nd cocaine in Females BXD
|
|
GS190949: GO:0009058 biosynthetic process
|
|
GS197037: GO:0010885 regulation of cholesterol storage
|
|
GS165537: MP:0005376 homeostasis/metabolism phenotype
|
|
GS199304: GO:0001085 RNA polymerase II transcription factor binding
|
|
GS182705: GO:0051173 positive regulation of nitrogen compound metabolic process
|
|
GS209960: GO:0003008 system process
|
|
GS185046: GO:0043112 receptor metabolic process
|
|
GS194309: GO:0016042 lipid catabolic process
|
|
GS206402: GO:0010745 negative regulation of macrophage derived foam cell differentiation
|
|
GS193784: GO:0072363 regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter
|
|
GS178151: GO:0008217 regulation of blood pressure
|
|
GS122972: 8-hydroxyeicosatetraenoic acid interacting genes (MeSH:C047628) in CTD
|
|
GS203593: GO:0043227 membrane-bounded organelle
|
|
GS181429: GO:0006631 fatty acid metabolic process
|
|
GS201265: GO:0009891 positive regulation of biosynthetic process
|
|
GS201922: GO:0019318 hexose metabolic process
|
|
GS177308: GO:1901362 organic cyclic compound biosynthetic process
|
|
GS127127: Benzo(a)pyrene interacting genes (MeSH:D001564) in CTD
|
|
GS180719: GO:0042476 odontogenesis
|
|
GS186836: GO:0008270 zinc ion binding
|
|
GS124102: alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone interacting genes (MeSH:C043438) in CTD
|
|
GS124744: icariin interacting genes (MeSH:C056599) in CTD
|
|
GS183756: GO:0010605 negative regulation of macromolecule metabolic process
|
|
GS124583: L 663536 interacting genes (MeSH:C060893) in CTD
|
|
GS136478: periosteal circumference 3 (Pcir3, Published QTL Chr 15)
|
|
GS210000: GO:0044446 intracellular organelle part
|
|
GS179369: GO:0010887 negative regulation of cholesterol storage
|
|
GS197156: GO:0046320 regulation of fatty acid oxidation
|
|
GS202316: GO:0050789 regulation of biological process
|
|
GS194087: GO:0003674 molecular_function
|
|
GS191268: GO:0010033 response to organic substance
|
|
GS135437: bone mineral density 37 (Bmd37, Published QTL Chr 15)
|
|
GS179496: GO:0042157 lipoprotein metabolic process
|
|
GS184461: GO:0009891 positive regulation of biosynthetic process
|
|
GS198973: GO:0010878 cholesterol storage
|
|
GS123203: Picryl Chloride interacting genes (MeSH:D010853) in CTD
|
|
GS191058: GO:0030522 intracellular receptor mediated signaling pathway
|
|
GS124487: 3-((O-6-deoxymannopyranosyl-1-2-O-(xylopyranosyl-1-3)arabinopyranosyl)oxy)-21-glucopyranosyloxy-20-hydroxydammar-24-en-19-al interacting genes (MeSH:C517623) in CTD
|
|
GS167722: MP:0002655 abnormal keratinocyte morphology
|
|
GS168852: MP:0001596 hypotension
|
|
GS177356: GO:0003674 molecular_function
|
|
GS178885: GO:0003677 DNA binding
|
|
GS188916: GO:0044723 single-organism carbohydrate metabolic process
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS126524: mono-(2-ethylhexyl)phthalate interacting genes (MeSH:C016599) in CTD
|
|
GS170781: MP:0000180 abnormal circulating cholesterol level
|
|
GS178841: GO:0010565 regulation of cellular ketone metabolic process
|
|
GS180001: GO:0048646 anatomical structure formation involved in morphogenesis
|
|
GS185181: GO:0097371 MDM2/MDM4 family protein binding
|
|
GS122181: alpha-Linolenic Acid interacting genes (MeSH:D017962) in CTD
|
|
GS177309: GO:1901363 heterocyclic compound binding
|
|
GS193936: GO:0006367 transcription initiation from RNA polymerase II promoter
|
|
GS182030: GO:0051098 regulation of binding
|
|
GS193984: GO:0010906 regulation of glucose metabolic process
|
|
GS195897: GO:0044255 cellular lipid metabolic process
|
|
GS122204: GW0742 interacting genes (MeSH:C479979) in CTD
|
|
GS83984: cocaine related behavior 15 (Cocrb15, Published QTL, Chr 15)
|
|
GS188410: GO:0032774 RNA biosynthetic process
|
|
GS192471: GO:0048869 cellular developmental process
|
|
GS199862: GO:0032105 negative regulation of response to extracellular stimulus
|
|
GS127221: Oleic Acid interacting genes (MeSH:D019301) in CTD
|
|
GS180166: GO:0008152 metabolic process
|
|
GS191310: GO:1901214 regulation of neuron death
|
|
GS192093: GO:0000981 sequence-specific DNA binding RNA polymerase II transcription factor activity
|
|
GS123451: Tetrachloroethylene interacting genes (MeSH:D013750) in CTD
|
|
GS121739: trans-10,cis-12-conjugated linoleic acid interacting genes (MeSH:C496197) in CTD
|
|
GS201261: GO:0009895 negative regulation of catabolic process
|
|
GS207822: GO:0072366 regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter
|
|
GS123929: Rifampin interacting genes (MeSH:D012293) in CTD
|
|
GS206407: GO:0010742 macrophage derived foam cell differentiation
|
|
GS203072: GO:0090304 nucleic acid metabolic process
|
|
GS136245: methamphetamine response QTL 5 (Marq5, Published QTL Chr 15)
|
|
GS126673: Fish Oils interacting genes (MeSH:D005395) in CTD
|
|
GS192255: GO:0030258 lipid modification
|
|
GS177382: GO:0097159 organic cyclic compound binding
|
|
GS126445: Dehydroepiandrosterone interacting genes (MeSH:D003687) in CTD
|
|
GS183122: GO:0005975 carbohydrate metabolic process
|
|
GS183232: GO:0032868 response to insulin stimulus
|
|
GS195678: GO:0003700 sequence-specific DNA binding transcription factor activity
|
|
GS121735: perfluorobutyric acid interacting genes (MeSH:C033094) in CTD
|
|
GS184936: GO:0072361 regulation of glycolysis by regulation of transcription from RNA polymerase II promoter
|
|
GS199644: GO:0009991 response to extracellular stimulus
|
|
GS192509: GO:0006810 transport
|
|
GS164112: MP:0011019 abnormal adaptive thermogenesis
|
|
GS183826: GO:0044262 cellular carbohydrate metabolic process
|
|
GS197516: GO:0042476 odontogenesis
|
|
GS84285: cocaine related behavior (Published QTL, Chr 15)
|
|
GS207949: GO:0005996 monosaccharide metabolic process
|
|
GS121134: fomepizole interacting genes (MeSH:C010238) in CTD
|
|
GS163103: MP:0000003 abnormal adipose tissue morphology
|
|
GS169625: MP:0005437 abnormal glycogen level
|
|
GS196693: GO:0097186 amelogenesis
|
|
GS200993: GO:0044275 cellular carbohydrate catabolic process
|
|
GS166216: MP:0005164 abnormal response to injury
|
|
GS205543: GO:0070013 intracellular organelle lumen
|
|
GS199863: GO:0032102 negative regulation of response to external stimulus
|
|
GS189532: GO:0010745 negative regulation of macrophage derived foam cell differentiation
|
|
GS193812: GO:0006629 lipid metabolic process
|
|
GS167211: MP:0009602 abnormal keratohyalin granule morphology
|
|
GS169054: MP:0005438 abnormal glycogen homeostasis
|
|
GS121645: Oleylethanolamide interacting genes (MeSH:C440229) in CTD
|
|
GS124241: 9,11-linoleic acid interacting genes (MeSH:C046938) in CTD
|
|
GS87379: Table S2: The data provided represent genes showing differential expression using ANOVA. (Whole Table) [DRG]
provisional
|
|
GS187751: GO:0019222 regulation of metabolic process
|
|
GS183662: GO:0009755 hormone-mediated signaling pathway
|
|
GS115117: Free-choice ethanol consumption
|
|
GS166972: MP:0005178 increased circulating cholesterol level
|
|
GS182176: GO:0010878 cholesterol storage
|
|
GS185961: GO:0051049 regulation of transport
|
|
GS136551: proteinuria 4 (Ptnu4, Published QTL Chr 15)
|
|
GS193237: GO:0031325 positive regulation of cellular metabolic process
|
|
GS182845: GO:0009991 response to extracellular stimulus
|
|
GS195214: GO:0009987 cellular process
|
|
GS163934: MP:0001764 abnormal homeostasis
|
|
GS204204: GO:0006351 transcription, DNA-dependent
|
|
GS125182: Vitamin A interacting genes (MeSH:D014801) in CTD
|
|
GS180034: GO:0032502 developmental process
|
|
GS182183: GO:0010876 lipid localization
|
|
GS199124: GO:0051716 cellular response to stimulus
|
|
GS200648: GO:0044260 cellular macromolecule metabolic process
|
|
GS165525: MP:0010768 mortality/aging
|
|
GS135523: body weight QTL 12 (Bwtq12, Published QTL Chr 15)
|
|
GS180155: GO:0065009 regulation of molecular function
|
|
GS34003: Cerebellum Gene expression correlates of Open Field locomotion 15-30 min post cocaine in Females BXD
|
|
GS169025: MP:0001657 abnormal induced morbidity/mortality
|
|
GS194602: GO:0045944 positive regulation of transcription from RNA polymerase II promoter
|
|
GS184206: GO:0036293 response to decreased oxygen levels
|
|
GS185259: GO:0051252 regulation of RNA metabolic process
|
|
GS203642: GO:0006725 cellular aromatic compound metabolic process
|
|
GS123944: Griseofulvin interacting genes (MeSH:D006118) in CTD
|
|
GS187166: GO:0044708 single-organism behavior
|
|
GS197236: GO:0070482 response to oxygen levels
|
|
GS201025: GO:0071702 organic substance transport
|
|
GS125409: Triiodothyronine interacting genes (MeSH:D014284) in CTD
|
|
GS207923: GO:0034641 cellular nitrogen compound metabolic process
|
|
GS121953: Dietary Sucrose interacting genes (MeSH:D019422) in CTD
|
|
GS135836: fluctuating asymmetry QTL 9 (Faq9, Published QTL Chr 15)
|
|
GS165539: MP:0005375 adipose tissue phenotype
|
|
GS201749: GO:0072361 regulation of glycolysis by regulation of transcription from RNA polymerase II promoter
|
|
GS198263: GO:0005488 binding
|
|
GS126144: Okadaic Acid interacting genes (MeSH:D019319) in CTD
|
|
GS194040: GO:1901360 organic cyclic compound metabolic process
|
|
GS169502: MP:0010953 abnormal fatty acid oxidation
|
|
GS206355: GO:0023052 signaling
|
|
GS192918: GO:0050896 response to stimulus
|
|
GS188897: GO:0070166 enamel mineralization
|
|
GS124088: sudan III interacting genes (MeSH:C033006) in CTD
|
|
GS125669: Phenylephrine interacting genes (MeSH:D010656) in CTD
|
|
GS165962: MP:0004566 myocardial fiber degeneration
|
|
GS190067: GO:0018130 heterocycle biosynthetic process
|
|
GS202545: GO:0015718 monocarboxylic acid transport
|
|
GS84291: cocaine seizure (Published QTL, Chr 15)
|
|
GS83983: cocaine related behavior 14 (Cocrb14, Published QTL, Chr 15)
|
|
GS124576: Peroxisome Proliferators interacting genes (MeSH:D020025) in CTD
|
|
GS124145: GW 4064 interacting genes (MeSH:C412815) in CTD
|
|
GS188308: GO:0010243 response to organic nitrogen
|
|
GS123764: Docosahexaenoic Acids interacting genes (MeSH:D004281) in CTD
|
|
GS166596: MP:0005334 abnormal fat pad morphology
|
|
GS205266: GO:0032774 RNA biosynthetic process
|
|
GS190920: GO:0072369 regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter
|
|
GS195977: GO:0007154 cell communication
|
|
GS202079: GO:0051253 negative regulation of RNA metabolic process
|
|
GS136488: predicted fat percentage 4 (Pfat4, Published QTL Chr 15)
|
|
GS208822: GO:0044390 small protein conjugating enzyme binding
|
|
GS125086: 6-ethylchenodeoxycholic acid interacting genes (MeSH:C464660) in CTD
|
|
GS207935: GO:0007507 heart development
|
|
GS126510: Naproxen interacting genes (MeSH:D009288) in CTD
|
|
GS185637: GO:0070887 cellular response to chemical stimulus
|
|
GS135806: emotionality 2 (Emo2, Published QTL Chr 15)
|
|
GS179777: GO:0043565 sequence-specific DNA binding
|
|
GS194267: GO:0043170 macromolecule metabolic process
|
|
GS210357: GO:0044249 cellular biosynthetic process
|
|
GS180452: GO:0044237 cellular metabolic process
|
|
GS193614: GO:0071310 cellular response to organic substance
|
|
GS208149: GO:0050994 regulation of lipid catabolic process
|
|
GS136683: skull morphology 22 (Skull22, Published QTL Chr 15)
|
|
GS207966: GO:0030522 intracellular receptor mediated signaling pathway
|
|
GS164301: MP:0005418 abnormal circulating hormone level
|
|
GS198644: GO:0045923 positive regulation of fatty acid metabolic process
|
|
GS122273: Fatty Acids, Nonesterified interacting genes (MeSH:D005230) in CTD
|
|
GS204208: GO:0006352 DNA-dependent transcription, initiation
|
|
GS125288: 2-chloro-5-nitrobenzanilide interacting genes (MeSH:C457499) in CTD
|
|
GS206953: GO:0018130 heterocycle biosynthetic process
|
|
GS180263: GO:0010888 negative regulation of lipid storage
|
|
GS203057: GO:0048518 positive regulation of biological process
|
|
GS209189: GO:0030258 lipid modification
|
|
GS163842: MP:0000230 abnormal systemic arterial blood pressure
|
|
GS194499: GO:0044271 cellular nitrogen compound biosynthetic process
|
|
GS195144: GO:0016052 carbohydrate catabolic process
|
|
GS123768: Cyclosporine interacting genes (MeSH:D016572) in CTD
|
|
GS169935: MP:0006085 myocardial necrosis
|
|
GS180164: GO:0008150 biological_process
|
|
GS177357: GO:0003676 nucleic acid binding
|
|
GS205972: GO:0008015 blood circulation
|
|
GS162899: MP:0003982 increased cholesterol level
|
|
GS168995: MP:0009642 abnormal blood homeostasis
|
|
GS177531: GO:0043170 macromolecule metabolic process
|
|
GS194840: GO:0045912 negative regulation of carbohydrate metabolic process
|
|
GS170742: MP:0005023 abnormal wound healing
|
|
GS201861: GO:0043112 receptor metabolic process
|
|
GS196987: GO:0045596 negative regulation of cell differentiation
|
|
GS189746: GO:0050793 regulation of developmental process
|
|
GS205255: GO:0044238 primary metabolic process
|
|
GS207293: GO:0032879 regulation of localization
|
|
GS169829: MP:0005385 cardiovascular system phenotype
|
|
GS196772: GO:0048646 anatomical structure formation involved in morphogenesis
|
|
GS177214: GO:0006366 transcription from RNA polymerase II promoter
|
|
GS185921: GO:0004871 signal transducer activity
|
|
GS201258: GO:0009896 positive regulation of catabolic process
|
|
GS209281: GO:0010629 negative regulation of gene expression
|
|
GS177904: GO:0071495 cellular response to endogenous stimulus
|
|
GS182792: GO:0042060 wound healing
|
|
GS186562: GO:0009653 anatomical structure morphogenesis
|
|
GS123048: Tretinoin interacting genes (MeSH:D014212) in CTD
|
|
GS124490: Fructose interacting genes (MeSH:D005632) in CTD
|
|
GS207858: GO:0009059 macromolecule biosynthetic process
|
|
GS34126: Cerebellum Gene expression correlates of Open Field locomotion (cm) 15-30 min post 2nd cocaine in Females BXD
|
|
GS177721: GO:0051234 establishment of localization
|
|
GS187062: GO:0034505 tooth mineralization
|
|
GS122441: U 0126 interacting genes (MeSH:C113580) in CTD
|
|
GS186097: GO:2000113 negative regulation of cellular macromolecule biosynthetic process
|
|
GS126098: 5,8,11,14-Eicosatetraynoic Acid interacting genes (MeSH:D015117) in CTD
|
|
GS199922: GO:0005975 carbohydrate metabolic process
|
|
GS210163: GO:0006082 organic acid metabolic process
|
|
GS190954: GO:0009056 catabolic process
|
|
GS205791: GO:0031330 negative regulation of cellular catabolic process
|
|
GS125518: Fatty Acids interacting genes (MeSH:D005227) in CTD
|
|
GS122305: resveratrol interacting genes (MeSH:C059514) in CTD
|
|
GS135706: diabetes susceptibility QTL 2 (Dbsq2, Published QTL Chr 15)
|
|
GS184218: GO:0071704 organic substance metabolic process
|
|
GS125506: Valproic Acid interacting genes (MeSH:D014635) in CTD
|
|
GS164751: MP:0000607 abnormal hepatocyte morphology
|
|
GS193563: GO:0006950 response to stress
|
|
GS183097: GO:0043279 response to alkaloid
|
|
GS121100: fenofibric acid interacting genes (MeSH:C006012) in CTD
|
|
GS208956: GO:0006007 glucose catabolic process
|
|
GS189986: GO:0001103 RNA polymerase II repressing transcription factor binding
|
|
GS126769: Calcium interacting genes (MeSH:D002118) in CTD
|
|
GS183514: GO:0019219 regulation of nucleobase-containing compound metabolic process
|
|
GS183848: GO:0044260 cellular macromolecule metabolic process
|
|
GS186757: GO:0034654 nucleobase-containing compound biosynthetic process
|
|
GS169517: MP:0002656 abnormal keratinocyte differentiation
|
|
GS167188: MP:0001264 increased body size
|
|
GS186179: GO:0045934 negative regulation of nucleobase-containing compound metabolic process
|
|
GS34166: Cerebellum Gene expression correlates of Open Field rears 30-45 min post 2nd cocaine in Females BXD
|
|
GS166412: MP:0002118 abnormal lipid homeostasis
|
|
GS124648: Lipopolysaccharides interacting genes (MeSH:D008070) in CTD
|
|
GS198685: GO:0048522 positive regulation of cellular process
|
|
GS166120: MP:0002106 abnormal muscle physiology
|
|
GS201949: GO:0044699 single-organism process
|
|
GS190397: GO:0032879 regulation of localization
|
|
GS208954: GO:0006139 nucleobase-containing compound metabolic process
|
|
GS209028: GO:0000981 sequence-specific DNA binding RNA polymerase II transcription factor activity
|
|
GS163577: MP:0001552 increased circulating triglyceride level
|
|
GS190950: GO:0009059 macromolecule biosynthetic process
|
|
GS181568: GO:0006357 regulation of transcription from RNA polymerase II promoter
|
|
GS178461: GO:0009987 cellular process
|
|
GS192624: GO:0043231 intracellular membrane-bounded organelle
|
|
GS167702: MP:0003141 cardiac fibrosis
|
|
GS186743: GO:0043227 membrane-bounded organelle
|
|
GS192041: GO:0043169 cation binding
|
|
GS200759: GO:0019395 fatty acid oxidation
|
|
GS210507: GO:0006950 response to stress
|
|
GS127176: monobutyl phthalate interacting genes (MeSH:C028577) in CTD
|
|
GS124185: Plant Extracts interacting genes (MeSH:D010936) in CTD
|
|
GS165398: MP:0005450 abnormal energy expenditure
|
|
GS180799: GO:0006091 generation of precursor metabolites and energy
|
|
GS125514: Fatty Acids, Monounsaturated interacting genes (MeSH:D005229) in CTD
|
|
GS191043: GO:0005996 monosaccharide metabolic process
|
|
GS185146: GO:0043470 regulation of carbohydrate catabolic process
|
|
GS181892: GO:0048523 negative regulation of cellular process
|
|
GS193268: GO:0005575 cellular_component
|
|
GS194039: GO:1901363 heterocyclic compound binding
|
|
GS205133: GO:0031998 regulation of fatty acid beta-oxidation
|
|
GS188190: GO:0006807 nitrogen compound metabolic process
|
|
GS170736: MP:0000189 hypoglycemia
|
|
GS204317: GO:0009725 response to hormone stimulus
|
|
GS205693: GO:0032096 negative regulation of response to food
|
|
GS207797: GO:0030154 cell differentiation
|
|
GS207581: GO:0007275 multicellular organismal development
|
|
GS177720: GO:0051235 maintenance of location
|
|
GS205002: GO:0048856 anatomical structure development
|
|
GS125792: Ethanol interacting genes (MeSH:D000431) in CTD
|
|
GS126040: Tetracycline interacting genes (MeSH:D013752) in CTD
|
|
GS163852: MP:0001544 abnormal cardiovascular system physiology
|
|
GS202188: GO:0044248 cellular catabolic process
|
|
GS204133: GO:0009062 fatty acid catabolic process
|
|
GS207857: GO:0009058 biosynthetic process
|
|
GS185724: GO:0043436 oxoacid metabolic process
|
|
GS197534: GO:0019320 hexose catabolic process
|
|
GS205165: GO:0010243 response to organic nitrogen
|
|
GS166648: MP:0009605 decreased keratohyalin granule number
|
|
GS183071: GO:0032108 negative regulation of response to nutrient levels
|
|
GS206864: GO:0001103 RNA polymerase II repressing transcription factor binding
|
|
GS201023: GO:0071704 organic substance metabolic process
|
|
GS84287: cocaine induced activation (Published QTL, Chr 15)
|
|
GS126378: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid interacting genes (MeSH:D019377) in CTD
|
|
GS184566: GO:0019538 protein metabolic process
|
|
GS183063: GO:0032105 negative regulation of response to extracellular stimulus
|
|
GS189538: GO:0010743 regulation of macrophage derived foam cell differentiation
|
|
GS191106: GO:0044464 cell part
|
|
GS186227: GO:0090304 nucleic acid metabolic process
|
|
GS162846: MP:0009489 abnormal blood vessel endothelium morphology
|
|
GS204612: GO:0019222 regulation of metabolic process
|
|
GS181533: GO:0046872 metal ion binding
|
|
GS184189: GO:0044275 cellular carbohydrate catabolic process
|
|
GS125390: Aspirin interacting genes (MeSH:D001241) in CTD
|
|
GS127139: Indomethacin interacting genes (MeSH:D007213) in CTD
|
|
GS206408: GO:0010743 regulation of macrophage derived foam cell differentiation
|
|
GS182182: GO:0010871 negative regulation of receptor biosynthetic process
|
|
GS123990: perfluorooctanoic acid interacting genes (MeSH:C023036) in CTD
|
|
GS122887: muraglitazar interacting genes (MeSH:C500085) in CTD
|
|
GS167025: MP:0003953 abnormal hormone level
|
|
GS170580: MP:0008986 abnormal liver parenchyma morphology
|
|
GS194555: GO:0031974 membrane-enclosed lumen
|
|
GS203925: GO:0034505 tooth mineralization
|
|
GS34320: Cerebellum Gene expression correlates of Cocaine TOTAL locomotion (activity beam breaks) in Females BXD
|
|
GS164133: MP:0005076 abnormal cell differentiation
|
|
GS180259: GO:0010883 regulation of lipid storage
|
|
GS34052: Cerebellum Gene expression correlates of Open Field locomotion (cm) 45-60 min post cocaine in Females BXD
|
|
GS165574: MP:0009285 increased gonadal fat pad weight
|
|
GS180717: GO:0042475 odontogenesis of dentin-containing tooth
|
|
GS210266: GO:0032000 positive regulation of fatty acid beta-oxidation
|
|
GS190412: GO:2000678 negative regulation of transcription regulatory region DNA binding
|
|
GS203688: GO:0008270 zinc ion binding
|
|
GS203607: GO:0034654 nucleobase-containing compound biosynthetic process
|
|
GS192074: GO:1901575 organic substance catabolic process
|
|
GS125550: Bleomycin interacting genes (MeSH:D001761) in CTD
|
|
GS125436: quinoline interacting genes (MeSH:C037219) in CTD
|
|
GS178155: GO:0008219 cell death
|
|
GS135423: bleomycin-induced pulmonary fibrosis 4 (Blmpf4, Published QTL Chr 15)
|
|
GS122968: GW 7647 interacting genes (MeSH:C453899) in CTD
|
|
GS183714: GO:0035094 response to nicotine
|
|
GS125769: Nitrites interacting genes (MeSH:D009573) in CTD
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS209683: GO:0045820 negative regulation of glycolysis
|
|
GS168056: MP:0002628 hepatic steatosis
|
|
GS187708: GO:0009893 positive regulation of metabolic process
|
|
GS209762: GO:0070491 repressing transcription factor binding
|
|
GS204232: GO:0001071 nucleic acid binding transcription factor activity
|
|
GS208978: GO:0043169 cation binding
|
|
GS203019: GO:0045934 negative regulation of nucleobase-containing compound metabolic process
|
|
GS197478: GO:0009628 response to abiotic stimulus
|
|
GS135876: femur geometry 13 (Fmgty13, Published QTL Chr 15)
|
|
GS182595: GO:0019904 protein domain specific binding
|
|
GS35131: Cerebellum Gene expression correlates of Cocaine Sensitization - TOTAL locomotion ( cm in 1 hr) in Females BXD
|
|
GS122210: AICA ribonucleotide interacting genes (MeSH:C031143) in CTD
|
|
GS135977: wound healing/regeneration 4 (Heal4, Published QTL Chr 15)
|
|
GS195515: GO:0031667 response to nutrient levels
|
|
GS121481: Cholesterol, Dietary interacting genes (MeSH:D002791) in CTD
|
|
GS180156: GO:0065008 regulation of biological quality
|
|
GS183346: GO:0001666 response to hypoxia
|
|
GS200310: GO:0019217 regulation of fatty acid metabolic process
|
|
GS189484: GO:0023052 signaling
|
|
GS135714: diabesity 4 (Dbsty4, Published QTL Chr 15)
|
|
GS195643: GO:0003677 DNA binding
|
|
GS121576: Flufenamic Acid interacting genes (MeSH:D005439) in CTD
|
|
GS197041: GO:0010889 regulation of sequestering of triglyceride
|
|
GS198572: GO:0010604 positive regulation of macromolecule metabolic process
|
|
GS180737: GO:0019320 hexose catabolic process
|
|
GS196176: GO:0031624 ubiquitin conjugating enzyme binding
|
|
GS125856: osthol interacting genes (MeSH:C046627) in CTD
|